US Medicare Price Negotiation: Gaming FDA Approval Dates Could Delay Drug Selection

 
• By Cathy Kelly

The early February date for publishing the list of products eligible for price negotiations could dictate approval strategies for drugs with potential for big sales in Medicare going forward.

Early February may become an extremely busy period for FDA approvals. • Source: Shutterstock

More from Market Access

More from Pink Sheet